Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil for hemodynamic changes and muscle relaxation in total abdominal hysterectomy
IRCT20210415050976N9Phase 3Completed
- Sponsor
- Jahrom University of Medical Sciences
- Start
- Mar 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of remifentanil, sponsored by Jahrom University of Medical Sciences. Primary endpoints: Hemodynamic changes during surgery and Muscle relaxation / patient laxity. Started Mar 2022; status: completed.
02
Drugs
remifentanil
Beyond the preview
Go deeper on IRCT20210415050976N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210415050976N9.